STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Sera Prognostics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Sera Prognostics reported an insider notice to sell 5,800 Class A common shares with an aggregate market value of $14,734, planned on 08/08/2025 on NASDAQ. The shares were acquired the same day through Restricted Stock Unit vesting, and the sale is listed with Morgan Stanley Smith Barney LLC. The proposed sale equals approximately 0.015% of the 38,061,868 outstanding shares. In the prior three months the filer sold 6,374; 5,735; and 945 shares for combined gross proceeds of $25,196. The filer certifies no known material nonpublic information.

Positive

  • Sale originated from RSU vesting, indicating shares were acquired through compensation rather than open-market purchase
  • Transaction size is immaterial relative to outstanding shares (~0.015%), limiting potential market impact
  • Brokerage route disclosed: Morgan Stanley Smith Barney LLC is listed as the broker, consistent with standard execution channels
  • Recent prior sales disclosed, showing transparency about insider dispositions (13,054 shares sold in prior three months for $25,196)

Negative

  • None.

Insights

TL;DR Small insider sale from RSU vesting; negligible impact on market capitalization.

The notice shows a proposed sale of 5,800 shares valued at $14,734, representing roughly 0.015% of the 38.06 million shares outstanding. Recent sales in May and June totaled 13,054 shares for $25,196, indicating modest disposition of vested holdings rather than a large-scale divestiture. Given the tiny percentage of outstanding stock involved, the transaction is unlikely to move the market or materially affect the company's capital structure.

TL;DR Disclosure aligns with Rule 144 procedures; transactions stem from RSU vesting and are routed through a major broker.

The filing identifies Restricted Stock Unit vesting as the source of the shares and names Morgan Stanley Smith Barney LLC as the broker, consistent with routine insider sales and Rule 144 reporting. The seller provided the required representation that no material nonpublic information is known. From a compliance and governance perspective, the form contains the expected information for an insider disposing of vested awards.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Sera Prognostics (SERA) file in this Form 144?

The filing notifies a proposed sale of 5,800 Class A common shares with an aggregate market value of $14,734, planned for 08/08/2025 on NASDAQ.

How were the 5,800 shares acquired by the seller?

The shares were acquired via Restricted Stock Unit vesting on 08/08/2025 (the filing lists the acquisition as RSU vesting).

Who is the broker handling the proposed sale for SERA?

The broker named in the filing is Morgan Stanley Smith Barney LLC.

How large is the proposed sale versus Sera Prognostics' outstanding shares?

5,800 shares represent approximately 0.015% of the company's 38,061,868 outstanding shares (figures from the filing).

Has the filer sold other SERA shares recently?

Yes. In the past three months the filer sold 6,374 (gross $15,569), 5,735 (gross $8,224), and 945 (gross $1,403) shares, totaling 13,054 shares and $25,196 gross proceeds.
Sera Prognostics, Inc.

NASDAQ:SERA

SERA Rankings

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

130.45M
33.40M
10.8%
64.96%
1.88%
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY